Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 27241-115

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 27241-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex-125mg (Divalproex 125mg)

This is a medication package containing 100 delayed-release capsules of divalproex sodium. Each capsule contains 125mg of valproic acid. The packaging warns not to accept if the seal is broken or missing and includes storage instructions. The capsules can be swallowed or opened and placed on food for administration. Dosage information can be found in the package insert. The package is child-resistant and includes a medication guide for patients. Marketed by Ajanta Pharma USA Inc. and made in India.*

FDA Label Image

Figure3 (Divalproex Fig3)

FDA Label Image

Figure4 (Divalproex Fig4)

FDA Label Image

Figure5 (Divalproex Fig5)

FDA Label Image

Figure6 (Divalproex Fig6)

FDA Label Image

Figure1 (Divalproex Figure1)

FDA Label Image

Figure2 (Divalproex Figure2)

This appears to be a chart or table of some sort showing the reduction in CPS rate for high and low doses. It includes percentages of patients experiencing improvement, no change or worsening. However, without additional information/context, it is difficult to determine what CPS rate refers to or what the purpose of the chart is.*

FDA Label Image

Structure (Divalproex Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.